Fahim S.M.Hsu C.-H.FANG-JU LINQian J.Chou C.2021-07-062021-07-06202114740338https://scholars.lib.ntu.edu.tw/handle/123456789/569584Background: Knowledge regarding antidiabetic medication (ADM) use prior to breast cancer (BC) diagnosis remains limited. The objectives were to (1) evaluate if the prior use of ADM was associated with BC stage at diagnosis and (2) identify and compare patBreast cancer; diabetes; medicare beneficiaries; stage at diagnosis[SDGs]SDG3acarbose; albiglutide; alogliptin; antidiabetic agent; bromocriptine mesilate; canagliflozin; chlorpropamide; colesevelam; dapagliflozin; dulaglutide; empagliflozin; exendin 4; glibenclamide; glimepiride; glipizide; insulin; insulin degludec; insulin detejournal article10.1080/14740338.2021.1853703332079422-s2.0-85096966091